157 related articles for article (PubMed ID: 17766106)
21. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
22. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Fantin M; Marti M; Auberson YP; Morari M
J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.
Mony L; Triballeau N; Paoletti P; Acher FC; Bertrand HO
Bioorg Med Chem Lett; 2010 Sep; 20(18):5552-8. PubMed ID: 20692832
[TBL] [Abstract][Full Text] [Related]
24. Ifenprodil induced antinociception and decreased the expression of NR2B subunits in the dorsal horn after chronic dorsal root ganglia compression in rats.
Zhang W; Shi CX; Gu XP; Ma ZL; Zhu W
Anesth Analg; 2009 Mar; 108(3):1015-20. PubMed ID: 19224818
[TBL] [Abstract][Full Text] [Related]
25. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
[TBL] [Abstract][Full Text] [Related]
26. Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).
Le Bourdonnec B; Windh RT; Leister LK; Zhou QJ; Ajello CW; Gu M; Chu GH; Tuthill PA; Barker WM; Koblish M; Wiant DD; Graczyk TM; Belanger S; Cassel JA; Feschenko MS; Brogdon BL; Smith SA; Derelanko MJ; Kutz S; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
J Med Chem; 2009 Sep; 52(18):5685-702. PubMed ID: 19694468
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro characterization of trans- and cis-[(18)F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-3-fluoropiperidine-1-carboxylates as new potential PET radiotracer candidates for the NR2B subtype N-methyl-D-aspartate receptor.
Koudih R; Gilbert G; Dhilly M; Abbas A; Barré L; Debruyne D; Sobrio F
Eur J Med Chem; 2012 Jul; 53():408-15. PubMed ID: 22554495
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
[TBL] [Abstract][Full Text] [Related]
29. Bed nucleus of the stria terminalis N-methyl-D-aspartate receptors and nitric oxide modulate the baroreflex cardiac component in unanesthetized rats.
Alves FH; Crestani CC; Resstel LB; Correa FM
J Neurosci Res; 2009 May; 87(7):1703-11. PubMed ID: 19156861
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
Cai TB; Zou Z; Thomas JB; Brieaddy L; Navarro HA; Carroll FI
J Med Chem; 2008 Mar; 51(6):1849-60. PubMed ID: 18307295
[TBL] [Abstract][Full Text] [Related]
31. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
[TBL] [Abstract][Full Text] [Related]
32. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding.
Marinelli L; Cosconati S; Steinbrecher T; Limongelli V; Bertamino A; Novellino E; Case DA
ChemMedChem; 2007 Oct; 2(10):1498-510. PubMed ID: 17849398
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
Kawai M; Sakurada I; Morita A; Iwamuro Y; Ando K; Omura H; Sakakibara S; Masuda T; Koike H; Honma T; Hattori K; Takashima T; Mizuno K; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5537-42. PubMed ID: 17766107
[TBL] [Abstract][Full Text] [Related]
34. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
[TBL] [Abstract][Full Text] [Related]
35. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors.
Cox JM; Harper B; Mastracchio A; Leiting B; Sinha Roy R; Patel RA; Wu JK; Lyons KA; He H; Xu S; Zhu B; Thornberry NA; Weber AE; Edmondson SD
Bioorg Med Chem Lett; 2007 Aug; 17(16):4579-83. PubMed ID: 17562364
[TBL] [Abstract][Full Text] [Related]
37. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
38. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
[TBL] [Abstract][Full Text] [Related]
39. A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.
Davies DJ; Crowe M; Lucas N; Quinn J; Miller DD; Pritchard S; Grose D; Bettini E; Calcinaghi N; Virginio C; Abberley L; Goldsmith P; Michel AD; Chessell IP; Kew JN; Miller ND; Gunthorpe MJ
Bioorg Med Chem Lett; 2012 Apr; 22(7):2620-3. PubMed ID: 22366657
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
